MicroRNAs: Macro challenges on understanding human biological functions and neurological diseases

Current Molecular Medicine

Volumn 10, Issue 8, 2010, Pages 692-704

  Santos Reboucas C B ^a   Pimentel, M M G ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

microRNAs; miRNA dysregulation; Neurological diseases; Non coding RNAs; Therapy

Indexed keywords

MESSENGER RNA; MICRORNA; RNA INDUCED SILENCING COMPLEX; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; AUTISM; BASE PAIRING; BIOGENESIS; BIOLOGY; BIPOLAR DEPRESSION; DNA POLYMORPHISM; FETAL ALCOHOL SYNDROME; FRAGILE X SYNDROME; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUNTINGTON CHOREA; NEUROLOGIC DISEASE; PARKINSON DISEASE; PROGNOSIS; SCHIZOPHRENIA; SLEEP DISORDER; SPINOCEREBELLAR DEGENERATION;

3' UNTRANSLATED REGIONS; GENE SILENCING; GENETIC MARKERS; HUMANS; MICRORNAS; NERVOUS SYSTEM DISEASES;

EID: 78651311799     PISSN: 15665240     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652410793384169     Document Type: Article

References (133)

1. Bartel DP. Micro RNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
2. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-5.
3. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36: D154-8.
4. Jacobsen A, Krogh A, Kauppinen S, Lindow M. miRMaid: aunifiedprogramming interface for microRNA data resources. BMC Bioinformatics 2010; 11: 29.
5. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes andtranscription units. Genome Res 2004; 14: 1902-10.
6. Chong MM, Rasmussen JP, Rudensky AY, Littman DR. The RNAse III enzyme Drosha is critical in T cells for preventinglethal inflammatory disease. J Exp Med 2008; 205: 2005-17.
7. He Z, Kokkinaki M, Pant D, Gallicano GI, Dym M. Small RNAmolecules in the regulation of spermatogenesis. Reproduction 2009; 137: 901-11.
8. Kim YK, Yu J, Han TS, et al. Functional links betweenclustered microRNAs: suppression of cell-cycle inhibitors bymicroRNA clusters in gastric cancer. Nucleic Acids Res 2009; 37: 1672-81.
9. Baskerville S, Bartel DP. Microarray profiling of microRNAsreveals frequent coexpression with neighboring miRNAs andhost genes. RNA 2005; 11: 241-7.
10. Lee Y, Kim M, Han J, et al. Micro RNA genes are transcribedby RNA polymerase II. EMBO J 2004; 23: 4051-60.
11. Borchert GM, Lanier W, Davidson BL. RNA polymerase IIItranscribes human microRNAs. Nat Struct Mol Biol 2006; 13: 1097-101.
12. Song GJ, Zhang Y, Li M, et al. Atypical transcription ofmicroRNA gene fragments. Nucleic Acids Res 2010; 38: 2775-87.
13. Pawlicki JM, Steitz JA. Primary microRNA transcript retentionat sites of transcription leads to enhanced microRNAproduction. J Cell Biol 2008; 182: 61-76.
14. Köhler A, Hurt E. Exporting RNA from the nucleus to thecytoplasm. Nat Rev Mol Cell Biol 2007; 8: 761-73.
15. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004; 18: 3016-27.
16. Han J, Lee Y, Yeom KH, et al. Molecular basis for therecognition of primary microRNAs by the Drosha-DGCR8complex. Cell 2006; 125: 887-901.
17. Han J, Pedersen JS, Kwon SC, et al. Posttranscriptionalcrossregulation between Drosha and DGCR8. Cell 2009; 136: 75-84.
18. Ruby JG, Jan CH, Bartel DP. Intronic microRNA precursorsthat bypass Drosha processing. Nature 2007; 448: 83-6.
19. Barbato C, Ciotti MT, Serafino A, Calissano P, Cogoni C. Dicer expression and localization in post-mitotic neurons. Brain Res 2007; 1175: 17-27.
20. Schwarz DS, Hutvágner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzymecomplex. Cell 2003; 115: 199-208.
21. Okamura K, Phillips MD, Tyler DM, Duan H, Chou YT, Lai EC. The regulatory activity of microRNA* species hassubstantial influence on microRNA and 3' UTR evolution. Nat Struct Mol Biol 2008; 15: 354-63.
22. Hutvagner G, Simard MJ. Argonaute proteins: key players inRNA silencing. Nat Rev Mol Cell Biol 2008; 9: 22-32.
23. Höck J, Weinmann L, Ender C, et al. Proteomic andfunctional analysis of Argonaute-containing mRNA-proteincomplexes in human cells. EMBO Rep 2007; 8: 1052-60.
24. Meister G, Tuschl T. Mechanisms of gene silencing bydouble-stranded RNA. Nature 2004; 431: 343-9.
25. Vasudevan S, Tong Y, Steitz JA. Switching from repressionto activation: microRNAs can up-regulate translation. Science 2007; 318: 1931-4.
26. Ørom UA, Nielsen FC, Lund AH. Micro RNA-10a binds the5'UTR of ribosomal protein mRNAs and enhances theirtranslation. Mol Cell 2008; 30: 460-71.
27. Lee I, Ajay SS, Yook JI, et al. New class of microRNA targetscontaining simultaneous 5'-UTR and 3'-UTR interaction sites. Genome Res 2009; 19: 1175-83.
28. Kawahara Y, Megraw M, Kreider E, et al. Frequency and fateof microRNA editing in human brain. Nucleic Acids Res 2008; 36: 5270-80.
29. Liu N, Okamura K, Tyler DM, Phillips MD, Chung WJ, Lai EC. The evolution and functional diversification of animalmicroRNA genes. Cell Res 2008; 18: 985-96.
30. Tyler DM, Okamura K, Chung WJ, et al. Functionally distinctregulatory RNAs generated by bidirectional transcription andprocessing of microRNA loci. Genes Dev 2008; 22: 26-36.
31. Smalheiser NR, Torvik VI. Mammalian microRNAs derivedfrom genomic repeats. Trends Genet 2005; 21: 322-6.
32. Piriyapongsa J, Jordan IK. A family of human microRNAgenes from miniature inverted-repeat transposable elements. PLo S One 2007; 2: e203.
33. Piriyapongsa J, Mariño-Ramírez L, Jordan IK. Origin andevolution of human microRNAs from transposable elements. Genetics 2007; 176: 1323-37.
34. Calin GA, Croce CM. Chromosomal rearrangements andmicroRNAs: a new cancer link with clinical implications. JClin Invest 2007; 117: 2059-66.
35. Zhang L, Volinia S, Bonome T, et al. Genomic and epigeneticalterations deregulate microRNA expression in humanepithelial ovarian cancer. Proc Natl Acad Sci USA 2008; 105: 7004-9.
36. Yang N, Coukos G, Zhang L. Micro RNA epigeneticalterations in human cancer: one step forward in diagnosisand treatment. Int J Cancer 2008; 122: 963-8.
37. Duan R, Pak C, Jin P. Single nucleotide polymorphismassociated with mature miR-125a alters the processing ofpri-miRNA. Hum Mol Genet 2007; 16: 1124-31.
38. Seitz H, Zamore PD. Rethinking the microprocessor. Cell 2006; 125: 827-9.
39. Sethupathy P, Collins FS. Micro RNA target sitepolymorphisms and human disease. Trends Genet 2008; 24: 489-97.
40. Muotri AR, Gage FH. Generation of neuronal variability andcomplexity. Nature 2006; 441: 1087-93.
41. Berezikov E, Thuemmler F, van Laake LW, et al. Diversity ofmicroRNAs in human and chimpanzee brain. Nat Genet 2006; 38: 1375-7.
42. Miska EA, Alvarez-Saavedra E, Townsend M, et al. Microarray analysis of microRNA expression in thedeveloping mammalian brain. Genome Biol 2004; 5: R68.
43. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalianmicroRNAs uncovers a subset of brain-expressedmicroRNAs with possible roles in murine and humanneuronal differentiation. Genome Biol 2004; 5: R13.
44. Hohjoh H, Fukushima T. Expression profile analysis ofmicroRNA (miRNA) in mouse central nervous system using anew miRNA detection system that examines hybridizationsignals at every step of washing. Gene 2007; 391: 39-44.
45. Schratt GM, Tuebing F, Nigh EA, et al. A brain-specificmicroRNA regulates dendritic spine development. Nature 2006; 439: 283-9.
46. Mehler MF, Mattick JS. Non-coding RNAs in the nervoussystem. J Physiol 2006; 575: 333-41.
47. Ashraf SI, McLoon AL, Sclarsic SM, Kunes S. Synapticprotein synthesis associated with memory is regulated by theRISC pathway in Drosophila. Cell 2006; 124: 191-205.
48. Smirnova L, Gräfe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG. Regulation of miRNA expression during neuralcell specification. Eur J Neurosci 2005; 21: 1469-77.
49. Vo N, Klein ME, Varlamova O, et al. cAMP-response elementbinding protein-induced microRNA regulates neuronalmorphogenesis. Proc Natl Acad Sci USA 2005; 102: 16426-31.
50. Conaco C, Otto S, Han JJ, Mandel G. Reciprocal actions ofREST and a microRNA promote neuronal identity. Proc Natl Acad Sci USA 2006; 103: 2422-7.
51. Bilen J, Liu N, Burnett BG, Pittman RN, Bonini NM. Micro RNA pathways modulate polyglutamine-inducedneurodegeneration. Mol Cell 2006; 24: 157-63.
52. Kim J, Inoue K, Ishii J, et al. A Micro RNA feedback circuit inmidbrain dopamine neurons. Science 2007; 317: 1220-4.
53. Hébert SS, Horré K, Nicolaï L, et al. Loss of microRNAcluster miR-29a/b-1 in sporadic Alzheimer's diseasecorrelates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 2008; 105: 6415-20.
54. Santos-Rebouças CB, Pimentel MMG. In: Focus on Mental Retardation. New York: Nova Science Publishers 2007: pp.153-84.
55. Darnell JC, Fraser CE, Mostovetsky O, et al. Kissingcomplex RNAs mediate interaction between the Fragile-Xmental retardation protein KH2 domain and brainpolyribosomes. Genes Dev 2005; 19: 903-18.
56. Irwin SA, Patel B, Idupulapati M, et al. Abnormal dendriticspine characteristics in the temporal and visual cortices ofpatients with fragile-X syndrome: a quantitative examination. Am J Med Genet 2001; 98: 161-7.
57. Jin P, Zarnescu DC, Ceman S, et al. Biochemical andgenetic interaction between the fragile X mental retardationprotein and the microRNA pathway. Nat Neurosci 2004; 7: 113-7.
58. Lin SL, Chang SJ, Ying SY. First in vivo evidence ofmicroRNA-induced fragile X mental retardation syndrome. Mol Psychiatry 2006; 11: 616-7.
59. Plante I, Davidovic L, Ouellet DL, et al. Dicer-Derived Micro RNAs Are Utilized by the Fragile X Mental Retardation Protein for Assembly on Target RNAs. J Biomed Biotechnol 2006; 2006(4): 64347.
60. Yang L, Duan R, Chen D, Wang J, Chen D, Jin P. Fragile Xmental retardation protein modulates the fate of germlinestem cells in Drosophila. Hum Mol Genet 2007; 16: 1814-20.
61. Cheever A, Ceman S. Phosphorylation of FMRP inhibitsassociation with Dicer. RNA 2009; 15: 362-6.
62. Duan R, Jin P. Identification of messenger RNAs andmicroRNAs associated with fragile X mental retardationprotein. Methods Mol Biol 2006; 342: 267-76.
63. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human Micro RNA targets. PLo S Biol 2004; 2: e363.
64. Vasudevan S, Steitz JA. AU-rich-element-mediatedupregulation of translation by FXR1 and Argonaute 2. Cell 2007; 128: 1105-18.
65. Hagerman RJ, Leehey M, Heinrichs W, et al. Intentiontremor, parkinsonism, and generalized brain atrophy in malecarriers of fragile X. Neurology 2001; 57: 127-30.
66. Handa V, Saha T, Usdin K. The fragile X syndrome repeatsform RNA hairpins that do not activate the interferoninducibleprotein kinase, PKR, but are cut by Dicer. Nucleic Acids Res 2003; 31: 6243-8.
67. Chen W, Jensen LR, Gecz J, et al. Mutation screening ofbrain-expressed X-chromosomal miRNA genes in 464patients with nonsyndromic X-linked mental retardation. Eur J Hum Genet 2007; 15: 375-8.
68. Gil JM, Rego AC. Mechanisms of neurodegeneration inHuntington's disease. Eur J Neurosci 2008; 27: 2803-20.
69. Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL. Thebifunctional microRNA miR-9/miR-9* regulates REST andCo REST and is downregulated in Huntington's disease. JNeurosci 2008; 28: 14341-6.
70. Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ. Micro RNA-based gene dysregulation pathway inHuntington's disease. Neurobiol Dis 2008; 29: 438-45.
71. Klein ME, Lioy DT, Ma L, Impey S, Mandel G, Goodman RH. Homeostatic regulation of Me CP2 expression by a CREBinducedmicro RNA. Nat Neurosci 2007; 10: 1513-4.
72. Bilen J, Liu N, Bonini NM. A new role for microRNApathways: modulation of degeneration induced bypathogenic human disease proteins. Cell Cycle 2006; 5: 2835-8.
73. Lee Y, Samaco R, Gatchel J, Thaller C, Orr HT, Zoghbi HY. miE-19, miR-101, and miR-130 co-regulate ATXN1 levels topotentially modulate SCA1 pathogenesis. Nat Neurosci 2008; 11: 1137-9.
74. Persengiev S, Kondova I, Otting N, Koeppen AH, Bontrop RE. Genome-wide analysis of miRNA expression reveals apotential role for miR-144 in brain aging and spinocerebellarataxia pathogenesis. Neurobiol Aging 2010 [Epub ahead ofprint].
75. Abu-Elneel K, Liu T, Gazzaniga FS, et al. Heterogeneousdysregulation of microRNAs across the autism spectrum. Neurogenetics 2008; 9: 153-61.
76. Burbach JP, van der Zwaag B. Contact in the genetics ofautism and schizophrenia. Trends Neurosci 2009; 32: 69-72.
77. Perkins DO, Jeffries CD, Jarskog LF, et al. Micro RNAexpression in the prefrontal cortex of individuals withschizophrenia and schizoaffective disorder. Genome Biol 2007; 8: R27.
78. Beveridge NJ, Tooney PA, Carroll AP, et al. Dysregulation ofmiRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet 2008; 17: 1156-68.
79. Hansen T, Olsen L, Lindow M, et al. Brain expressedmicroRNAs implicated in schizophrenia etiology. PLo S One 2007; 2: e873.
80. Mellios N, Huang HS, Baker SP, Galdzicka M, Ginns E, Akbarian S. Molecular determinants of dysregulatedGABAergic gene expression in the prefrontal cortex ofsubjects with schizophrenia. Biol Psychiatry 2009; 65: 1006-14.
81. Kocerha J, Faghihi MA, Lopez-Toledano MA, et al. Micro RNA-219 modulates NMDA receptor-mediatedneurobehavioral dysfunction. Proc Natl Acad Sci USA 2009; 106: 3507-12.
82. Xu Y, Li F, Zhang B, et al. Micro RNAs and target sitescreening reveals a pre-microRNA-30e variant associatedwith schizophrenia. Schizophr Res 2010; 119: 219-27.
83. Debbané M, Glaser B, David MK, Feinstein C, Eliez S. Psychotic symptoms in children and adolescents with22q11.2 deletion syndrome: Neuropsychological andbehavioral implications. Schizophr Res 2006; 84: 187-93.
84. Bassett AS, Marshall CR, Lionel AC, Chow EW, Scherer SW. Copy number variations and risk for schizophrenia in22q11.2 deletion syndrome. Hum Mol Genet 2008; 17: 4045-53.
85. Stark KL, Xu B, Bagchi A, et al. Animal Micro RNAs conferrobustness to gene expression and have a significant impacton 3'UTR evolution. Nat Genet 2008; 40: 751-60.
86. Burmistrova OA, Goltsov AY, Abramova LI, Kaleda VG, Orlova VA, Rogaev EI. Micro RNA in schizophrenia: geneticand expression analysis of miR-130b (22q11). Biochemistry(Mosc) 2007; 72: 578-82.
87. Zhu Y, Kalbfleisch T, Brennan MD, Li Y. A Micro RNA gene ishosted in an intron of a schizophrenia-susceptibility gene. Schizophr Res 2009; 109: 86-9.
88. Zhou R, Yuan P, Wang Y, et al. Evidence for selectivemicroRNAs and their effectors as common long-term targetsfor the actions of mood stabilizers. Neuropsychopharmacology 2009; 34: 395-405.
89. Abelson JF, Kwan KY, O'Roak BJ, et al. Sequence variantsin SLITRK1 are associated with Tourette's syndrome. Science 2005; 310: 317-20.
90. Bertram L, Tanzi RE. Thirty years of Alzheimer's diseasegenetics: the implications of systematic meta-analyses. Nat Rev Neurosci 2008; 9: 768-78.
91. Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G. Increased expression of the amyloid precursor betasecretasein Alzheimer's disease. Ann Neurol 2002; 51: 783-6.
92. Boissonneault V, Plante I, Rivest S, Provost P. Micro RNA-298 and microRNA-328 regulate expression of mouse betaamyloidprecursor protein-converting enzyme 1. J Biol Chem 2009; 284: 1971-81
93. Niwa R, Zhou F, Li C, Slack FJ. The expression of theAlzheimer's amyloid precursor protein-like gene is regulatedby developmental timing microRNAs and their targets inCaenorhabditis elegans. Dev Biol 2008; 315: 418-25.
94. Vilardo E, Barbato C, Ciotti M, Cogoni C, Ruberti F. Micro RNA-101 regulates amyloid precursor proteinexpression in hippocampal neurons. J Biol Chem 2010; 285: 18344-51.
95. Wang WX, Rajeev BW, Stromberg AJ, et al. The expressionof microRNA miR-107 decreases early in Alzheimer'sdisease and may accelerate disease progression throughregulation of beta-site amyloid precursor protein-cleavingenzyme 1. J Neurosci 2008; 28: 1213-23.
96. Garzon R, Liu S, Fabbri M, et al. Micro RNA-29b inducesglobal DNA hypomethylation and tumor suppressor genereexpression in acute myeloid leukemia by targeting directlyDNMT3A and 3B and indirectly DNMT1. Blood 2009; 113: 6411-8.
97. Mattson MP. Methylation and acetylation in nervous systemdevelopment and neurodegenerative disorders. Ageing Res Rev 2003; 2: 329-42.
98. Bettens K, Brouwers N, Engelborghs S, et al. APP andBACE1 miRNA genetic variability has no major role in risk forAlzheimer disease. Hum Mut 2009; 30: 1207-13.
99. Wilfred BR, Wang WX, Nelson PT. Energizing miRNAresearch: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates humanmetabolic pathways. Mol Genet Metab 2007; 91: 209-17.
100. Joglekar MV, Parekh VS, Hardikar AA. New pancreas fromold: microregulators of pancreas regeneration. Trends Endocrinol Metab 2007; 18: 393-400.
101. Lukiw WJ. Micro-RNA speciation in fetal, adult andAlzheimer's disease hippocampus. Neuroreport 2007; 18: 297-300.
102. Wang X, Liu P, Zhu H, et al. miR-34a, a microRNA upregulatedin a double transgenic mouse model of Alzheimer'sdisease, inhibits bcl2 translation. Brain Res Bull 2009; 80: 268-73.
103. Hohn T, Vyas V, Hernandez-Estrada T, Nichol KE, Christie LA, Head E. Lack of Pathology in a Triple Transgenic Mouse Model of Alzheimer's Disease after Overexpression of theAnti-Apoptotic Protein Bcl-2. J Neurosci 2008; 28: 3051-9.
104. Lukiw WJ, Pogue AI. Induction of specific micro RNA(miRNA) species by ROS-generating metal sulfates inprimary human brain cells. J Inorg Biochem 2007; 101: 1265-9.
105. Alexandrov PN, Zhao Y, Pogue AI, et al. Synergistic effectsof iron and aluminum on stress-related gene expression inprimary human neural cells. J Alzheimers Dis 2005; 8: 117-27.
106. Lukiw WJ, Zhao Y, Cui JG. An NF-kappaB-sensitive microRNA-146a-mediated inflammatory circuit in Alzheimerdisease and in stressed human brain cells. J Biol Chem 2008; 283: 31315-22.
107. Sethi P, Lukiw WJ. Micro-RNA abundance and stability inhuman brain: specific alterations in Alzheimer's diseasetemporal lobe neocortex. Neurosci Lett 2009; 459: 100-4.
108. Rademakers R, Eriksen JL, Baker M, et al. Commonvariation in the miR-659 binding-site of GRN is a major riskfactor for TDP43-positive frontotemporal dementia. Hum Mol Genet 2008; 17: 3631-42.
109. Wang G, van der Walt JM, Mayhew G, et al. Variation in themiRNA-433 binding site of FGF20 confers risk for Parkinsondisease by overexpression of alpha-synuclein. Am J Hum Genet 2008; 82: 283-9.
110. Singleton AB, Farrer M, Johnson J, et al. Alpha-Synucleinlocus triplication causes Parkinson's disease. Science 2003; 302: 841.
111. Chartier-Harlin MC, Kachergus J, Roumier C, et al. Alphasynucleinlocus duplication as a cause of familial Parkinson'sdisease. Lancet 2004; 364: 1167-9.
112. Junn E, Lee KW, Jeong BS, Chan TW, Im JY, Mouradian MM. Repression of MM-synuclein expression and toxicity bymicroRNA-7. PNAS 2009; 106: 13052-7.
113. Santosh PS, Arora N, Sarma P, Pal-Bhadra M, Bhadra U. Interaction map and selection pf microRNA targets inParkinsonśs disease-related genes. J Biomed Biotechnol 2009; 2009: 363145.
114. Davis CJ, Bohnet SG, Meyerson JM, Krueger JM. Sleep losschanges microRNA levels in the brain: a possible mechanismfor state-dependent translational regulation. Neurosci Lett 2007; 422: 68-73.
115. Sathyan P, Golden HB, Miranda RC. Competing interactionsbetween micro-RNAs determine neural progenitor survivaland proliferation after ethanol exposure: evidence from an exvivo model of the fetal cerebral cortical neuroepithelium. JNeurosci 2007; 27: 8546-57.
116. Wang LL, Zhang Z, Li Q, et al. Ethanol exposure inducesdifferential microRNA and target gene expression andteratogenic effects which can be suppressed by folic acidsupplementation. Hum Reprod 2009; 24: 562-79.
117. Liu CG, Calin GA, Meloon B, et al. An oligonucleotidemicrochip for genome-wide microRNA profiling in human andmouse tissues. Proc Natl Acad Sci USA 2004; 101: 9740-4.
118. Nelson PT, Baldwin DA, Kloosterman WP, et al. RAKE andLNA-ISH reveal microRNA expression and localization inarchival human brain. RNA 2006; 12: 187-91.
119. Mestdagh P, Feys T, Bernard N, et al. High-throughput stemloopRT-qPCR miRNA expression profiling using minuteamounts of input RNA. Nucleic Acids Res 2008; 36: e143.
120. Siva AC, Nelson LJ, Fleischer CL, et al. Molecular assays forthe detection of microRNAs in prostate cancer. Mol Cancer 2009; 8: 17.
121. Cummins JM, He Y, Leary RJ, et al. The colorectalmicroRNAome. Proc Natl Acad Sci USA 2006; 103: 3687-92.
122. Git A, Dvinge H, Salmon-Divon M, et al. Systematiccomparison of microarray profiling, real-time PCR, and nextgenerationsequencing technologies for measuringdifferential microRNA expression. RNA 2010; 16: 991-1006.
123. Bartel DP. Micro RNAs: target recognition and regulatoryfunctions. Cell 2009; 136: 215-33.
124. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. Phylogenetic shadowing and computationalidentification of human microRNA genes. Cell 2005; 120: 21-4.
125. Tran DH, Satou K, Ho TB. Finding microRNA regulatorymodules in human genome using rule induction. BMCBioinformatics 2008; 9 Suppl 12: S5.
126. Farh KK, Grimson A, Jan C, et al. The widespread impact ofmammalian Micro RNAs on mRNA repression and evolution. Science 2005; 310: 1817-21.
127. Davis S, Lollo B, Freier S, Esau C. Improved targeting ofmiRNA with antisense oligonucleotides. Nucleic Acids Res 2006; 34: 2294-304.
128. Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipidmetabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3: 87-98.
129. Hutvagner G, Simard MJ, Mello CC, Zamore PD. Sequencespecificinhibition of small RNA function. PLo S Biol 2004; 2:E98.
130. Kurreck J, Wyszko E, Gillen C, Erdmann VA. Design ofantisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res 2002; 30: 1911-8.
131. Ørom UA, Kauppinen S, Lund AH. LNA-modifiedoligonucleotides mediate specific inhibition of microRNAfunction. Gene 2006; 372: 137-141.
132. Krützfeldt J, Rajewsky N, Braich R, et al. Silencing ofmicroRNAs in vivo with 'antagomirs'. Nature 2005; 438: 685-9.
133. Colin A, Faideau M, Dufour N, et al. Engineered lentiviralvector targeting astrocytes in vivo. Glia 2009; 57: 667-79.